• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名携带HRPT2种系突变的复发性散发性原发性甲状旁腺功能亢进患者中HRPT2基因的不同体细胞改变。

Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.

作者信息

Cetani F, Pardi E, Ambrogini E, Viacava P, Borsari S, Lemmi M, Cianferotti L, Miccoli P, Pinchera A, Arnold A, Marcocci C

机构信息

Department of Endocrinology and Metabolism, University of Pise, Pise, Italy.

出版信息

Endocr Relat Cancer. 2007 Jun;14(2):493-9. doi: 10.1677/ERC-06-0092.

DOI:10.1677/ERC-06-0092
PMID:17639062
Abstract

Early onset of primary hyperparathyroidism (PHPT) and multiglandular involvement suggest a familial form in which germline mutation of a PHPT-related gene(s) and a somatic event at the same locus can be often demonstrated. We investigated the involvement of multiple endocrine neoplasia type 1 (MEN1) and HRPT2 genes in a 39-year-old man with recurrent PHPT. PHPT was firstly diagnosed at the age of 21 and the patient had two recurrences separated by extended periods of normocalcemia. This unusual history prompted us to investigate other family members and study the MEN1 and HRPT2 genes. An HRPT2 germline missense mutation in exon 3 (R91P) was found in the index case, which was associated with different HRPT2 somatic alterations in each of the three examined parathyroid tumors. These findings are consistent with Knudson's 'two hit' concept of biallelic inactivation of classical tumor suppressor genes. Screening of 15 asymptomatic relatives was negative for the R91P germline mutation. All the three abnormal parathyroid specimens showed cystic features at histology and were negative for parafibromin immunostaining. In one specimen, diffuse parafibromin staining was evident in a rim of normal parathyroid tissue surrounding the adenomatous lesion. Our study shows that different somatic genetic events at the HRPT2 locus are responsible for the asynchronous occurrence of multiple adenomas in a patient carrying an HRPT2 germline mutation. The finding of diffuse parafibromin staining in a rim of normal parathyroid tissue, but not in the contiguous adenomatous lesion, reinforces the concept that loss of parafibromin expression is responsible for the development of parathyroid tumors in this setting.

摘要

原发性甲状旁腺功能亢进症(PHPT)的早发及多腺体受累提示为家族性形式,其中常可证实PHPT相关基因的种系突变以及同一基因座的体细胞事件。我们调查了1型多发性内分泌腺瘤病(MEN1)和HRPT2基因在一名复发性PHPT的39岁男性中的作用。PHPT最初在21岁时被诊断出,该患者有两次复发,中间间隔长时间的血钙正常。这一不同寻常的病史促使我们调查其他家庭成员并研究MEN1和HRPT2基因。在索引病例中发现了外显子3中的HRPT2种系错义突变(R91P),这与三个检查的甲状旁腺肿瘤中每一个的不同HRPT2体细胞改变相关。这些发现与Knudson经典肿瘤抑制基因双等位基因失活的“两次打击”概念一致。对15名无症状亲属的筛查结果显示R91P种系突变呈阴性。所有三个异常甲状旁腺标本在组织学上均显示囊性特征,且甲状旁腺素免疫染色呈阴性。在一个标本中,腺瘤样病变周围正常甲状旁腺组织边缘可见弥漫性甲状旁腺素染色。我们的研究表明,HRPT2基因座处不同的体细胞遗传事件是携带HRPT2种系突变患者中多个腺瘤异步发生的原因。在正常甲状旁腺组织边缘而非相邻腺瘤样病变中发现弥漫性甲状旁腺素染色,强化了在这种情况下甲状旁腺素表达缺失是甲状旁腺肿瘤发生原因的概念。

相似文献

1
Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.一名携带HRPT2种系突变的复发性散发性原发性甲状旁腺功能亢进患者中HRPT2基因的不同体细胞改变。
Endocr Relat Cancer. 2007 Jun;14(2):493-9. doi: 10.1677/ERC-06-0092.
2
Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.侵袭性甲状旁腺疾病早期检测的监测:与种系HRPT2突变相关的家族性孤立性甲状旁腺功能亢进症中的癌和非典型腺瘤。
J Bone Miner Res. 2006 Oct;21(10):1666-71. doi: 10.1359/jbmr.060702.
3
Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.家族性孤立性甲状旁腺功能亢进症和甲状旁腺功能亢进-颌骨肿瘤综合征患者的基因分析。
Clin Endocrinol (Oxf). 2006 Jul;65(1):9-16. doi: 10.1111/j.1365-2265.2006.02534.x.
4
Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas.鉴定石蜡包埋(散发性)甲状旁腺癌中的 MEN1 和 HRPT2 体细胞突变。
Clin Endocrinol (Oxf). 2007 Sep;67(3):370-6. doi: 10.1111/j.1365-2265.2007.02894.x. Epub 2007 Jun 6.
5
Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.家族性孤立性甲状旁腺功能亢进症的遗传学分析:对临床评估和手术管理的意义
Clin Endocrinol (Oxf). 2006 Feb;64(2):146-52. doi: 10.1111/j.1365-2265.2006.02438.x.
6
Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.家族性甲状旁腺功能亢进症:三个携带种系HRPT2突变的家族经过30年随访后的手术结果
Surgery. 2008 May;143(5):630-40. doi: 10.1016/j.surg.2007.12.012. Epub 2008 Mar 17.
7
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.散发性甲状旁腺癌中HRPT2基因的体细胞和生殖系突变。
N Engl J Med. 2003 Oct 30;349(18):1722-9. doi: 10.1056/NEJMoa031237.
8
Loss of parafibromin expression in a subset of parathyroid adenomas.一部分甲状旁腺腺瘤中副纤维蛋白表达缺失。
Endocr Relat Cancer. 2006 Jun;13(2):509-23. doi: 10.1677/erc.1.01058.
9
Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.副纤维蛋白核表达缺失可将甲状旁腺癌和与甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征相关的腺瘤与散发性甲状旁腺腺瘤及增生区分开来。
Am J Surg Pathol. 2006 Sep;30(9):1140-9. doi: 10.1097/01.pas.0000209827.39477.4f.
10
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.CDC73/HRPT2 启动子 CpG 岛甲基化和 5'非翻译区突变是甲状旁腺瘤中抑 parafibromin 的少见机制。
Endocr Relat Cancer. 2010 Feb 18;17(1):273-82. doi: 10.1677/ERC-09-0291. Print 2010 Mar.

引用本文的文献

1
The Consistency of Mutation and Parafibromin Staining Loss in Parathyroid Neoplasm: A Systematic Review.甲状旁腺肿瘤中突变与副纤维蛋白染色缺失的一致性:一项系统评价
Int J Endocrinol. 2025 Aug 20;2025:1905585. doi: 10.1155/ije/1905585. eCollection 2025.
2
Late-onset postsurgical hypoparathyroidism following parathyroidectomy for recurrent primary hyperparathyroidism: a case report and literature review.复发性原发性甲状旁腺功能亢进症甲状旁腺切除术后迟发性术后甲状旁腺功能减退症:一例报告及文献复习
Endocrine. 2020 Aug;69(2):402-409. doi: 10.1007/s12020-020-02344-y. Epub 2020 May 21.
3
Clinical Features, Treatment, and Surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: An Up-to-Date and Review of the Literature.
甲状旁腺功能亢进-颌骨肿瘤综合征的临床特征、治疗及监测:文献综述与最新进展
Int J Endocrinol. 2019 Dec 18;2019:1761030. doi: 10.1155/2019/1761030. eCollection 2019.
4
A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.一名因罕见种系 HRPT2/CDC73 突变导致的副甲状腺癌的年轻男性。
Endocr Pathol. 2018 Dec;29(4):374-379. doi: 10.1007/s12022-018-9552-5.
5
Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.人 CDC73 氨基端结构域的晶体结构及其对甲状旁腺功能亢进-颌骨肿瘤(HPT-JT)综合征的影响。
Sci Rep. 2017 Nov 15;7(1):15638. doi: 10.1038/s41598-017-15715-9.
6
Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio.全段甲状旁腺激素/完整甲状旁腺激素比值异常的继发性甲状旁腺功能亢进中钙敏感受体和 parafibromin 的表达降低。
Clin Kidney J. 2013 Aug;6(4):429-32. doi: 10.1093/ckj/sft061.
7
Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES).遗传性甲状旁腺功能亢进症——欧洲内分泌外科医生协会(ESES)共识报告
Langenbecks Arch Surg. 2015 Dec;400(8):867-86. doi: 10.1007/s00423-015-1342-7. Epub 2015 Oct 8.
8
Hyperparathyroidism-jaw tumor syndrome: Results of operative management.甲状旁腺功能亢进-颌骨肿瘤综合征:手术治疗结果
Surgery. 2014 Dec;156(6):1315-24; discussion 1324-5. doi: 10.1016/j.surg.2014.08.004. Epub 2014 Oct 16.
9
Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).撒丁岛一个患有4型多发性内分泌肿瘤(MEN4)的家族中CDKN1B突变的功能特征分析
Endocr Connect. 2015 Mar;4(1):1-8. doi: 10.1530/EC-14-0116. Epub 2014 Nov 21.
10
Identification of a germline mutation in the HRPT2 gene in a Chinese family with parathyroid carcinomas.在中国一个甲状旁腺癌家系中鉴定出HRPT2基因的种系突变。
Intractable Rare Dis Res. 2012 Feb;1(1):27-9. doi: 10.5582/irdr.2012.v1.1.27.